Title : Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients.

Pub. Date : 2015 Dec

PMID : 26271661






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CYP3A5*3, CYP3A4*1B and CYP3A4*22 alleles of liver grafts may explain about one third of the inter-individual differences in pharmacokinetics of ciclosporin and tacrolimus in recipients. Cyclosporine cytochrome P450 family 3 subfamily A member 5 Homo sapiens
2 RESULTS: The recipients with grafts from normal CYP3A4 expresser donors carrying CYP3A5*3/*3 required CNI maintenance doses more or less similar to the bodyweight-controlled starting doses (9.1 mg kg(-1) of ciclosporin and 0.1 mg kg(-1) of tacrolimus). Cyclosporine cytochrome P450 family 3 subfamily A member 5 Homo sapiens